The role of insulin pump therapy for type 2 diabetes mellitus

被引:23
作者
Landau, Zohar [1 ,2 ]
Raz, Itamar [3 ]
Wainstein, Julio [2 ]
Bar-Dayan, Yosefa [2 ]
Cahn, Avivit [3 ]
机构
[1] E Wolfson Med Ctr, Pediatr Endocrine & Diabet Unit, Holon, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[3] Hadassah Univ Hosp, Dept Internal Med, Diabet Unit, Jerusalem, Israel
关键词
continuous subcutaneous insulin infusion; insulin pump; multiple daily injections; type; 2; diabetes; diabetes control; MULTIPLE DAILY INJECTIONS; BETA-CELL FUNCTION; TERM GLYCEMIC CONTROL; GLUCOSE VARIABILITY; PARALLEL-GROUP; INFUSION CSII; OLDER-ADULTS; IMPROVEMENT; HYPOGLYCEMIA; EFFICACY;
D O I
10.1002/dmrr.2822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many patients with type 2 diabetes fail to achieve adequate glucose control despite escalation of treatment and combinations of multiple therapies including insulin. Patients with long-standing type 2 diabetes often suffer from the combination of severe insulin deficiency in addition to insulin resistance, thereby requiring high doses of insulin delivered in multiple injections to attain adequate glycemic control. Insulin-pump therapy was first introduced in the 1970s as an approach to mimic physiological insulin delivery and attain normal glucose in patients with type 1 diabetes. The recent years have seen an increase in the use of this technology for patients with type 2 diabetes. This article summarizes the clinical studies evaluating insulin pump use in patients with type 2 diabetes and discusses the benefits and shortcomings of pump therapy in this population. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页数:13
相关论文
共 75 条
[11]   Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment [J].
Chen, Ailing ;
Huang, Zhimin ;
Wan, Xuesi ;
Deng, Wanping ;
Wu, Jiyan ;
Li, Licheng ;
Cai, Qiuling ;
Xiao, Haipeng ;
Li, Yanbing .
DIABETES CARE, 2012, 35 (03) :474-481
[12]   Improvement of -cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control [J].
Choi, Soo-Bong ;
Lee, Jun-Ho ;
Lee, Ju-Han ;
Kim, Seonguk ;
Han, Sang-Don ;
Kim, Ick-Hee ;
Noh, Yun-Hee .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2013, 29 (06) :473-482
[13]   Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2GoalSM concept [J].
Cohen, O. ;
Agabria, Z. ;
Lysyy, L. ;
Ianovitsky, Y. ;
Nguyen, X. ;
Fung, M. ;
Lee, S. ;
Wainstein, J. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (06) :627-633
[14]  
David G, 2014, AM J MANAG CARE, V20, pE490
[15]   Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004 [J].
Dodd, Allison Hedley ;
Colby, Margaret S. ;
Boye, Kristina S. ;
Fahlman, Cheryl ;
Kim, Sunny ;
Briefel, Ronette R. .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) :1605-1613
[16]   Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen [J].
Edelman, Steven V. ;
Bode, Bruce W. ;
Bailey, Timothy S. ;
Kipnes, Mark S. ;
Brunelle, Rocco ;
Chen, Xiaojing ;
Frias, Juan P. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (08) :627-633
[17]   Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections [J].
Fatourechi, Mitra M. ;
Kudva, Yogish C. ;
Murad, M. Hassan ;
Elamin, Mohamed B. ;
Tabini, Claudia C. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (03) :729-740
[18]  
Frias Juan P, 2011, J Diabetes Sci Technol, V5, P887
[19]   Effect of a multifactorial intervention on mortality in type 2 diabetes [J].
Gaede, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :580-591
[20]   Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes [J].
Gao, Guan-Qi ;
Heng, Xue-Yuan ;
Wang, Yue-Li ;
Li, Wen-Xia ;
Dong, Qing-Yu ;
Liang, Cui-Ge ;
Du, Wen-Hua ;
Liu, Xiao-Meng .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (04) :1191-1196